The latest venture capital, seed, pre-seed, and angel deals for NYC startups for 10/2/2026 featuring funding details for TriGemX Bio, Walapay, and much more. This page will be updated throughout the day to reflect any new fundings.
TriGemX Bio – $94M
BioTechHealthTech
TriGemX Bio, a biotech company that develops a first-in-class oral medicine for the treatment of migraine, has raised $94M in Venture funding led by The Column Group, TCG Crossover, and Viking Global Investors. Founded by Charles Zuker, Richard Axel, and Thomas Maniatis in 2015, TriGemX Bio has now raised a total of $573M in reported equity funding. The company, formerly known as Kallyope, relaunched under the new TriGemX Bio name alongside the financing.
YOUR BRAND. NYC TECH.
AlleyWatch puts your message in front of the investors, operators, and entrepreneurs driving NY’s innovation economy. Advertise today →
Walapay – $4.6M
FinTech
Walapay, a payments infrastructure company that provides a single API for account issuance, collections, currency exchange, and payouts across borders, has raised $4.6M in Seed funding led by Generative Ventures with participation from Commerce Ventures, Polygon Labs, Verda Ventures, NGC Ventures, FGV Capital, Jsquare, Knollwood Investment Advisory, Big Brain Holdings, Reflexive Capital, and Contribution Capital. Walapay was founded by Tom Borgers and Dimitri Borgers in 2022.
You are seconds away from signing up for the hottest list in NYC Tech!
